Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Roystone Capital Partners Adds To Position In Sinclair Broadcast Group Inc (SBGI)

Richard Barrera is still optimistic about the prospects of Sinclair Broadcast Group Inc (NASDAQ:SBGI) and has further boosted his fund’s stake in the company. Barrera’s Roystone Capital Partners has disclosed the addition of 282,800 shares to its portfolio in a recent filing with the Securities and Exchange Commission. Following this move, Barrera and Roystone have amassed 3.78 million shares of Sinclair Broadcast Group Inc (NASDAQ:SBGI), which account for 5.3% of the company’s common stock.

Sinclair Broadcast Group, Inc. (NASDAQ:SBGI)

Eric W. Mandelblatt, the manager of Soroban Capital Partners, has also become a fan of this company and has initiated a position for his fund during the first quarter of this year. In its latest 13F filing, Soroban Capital has reported ownership of 3.44 million shares of Sinclair Broadcast Group Inc (NASDAQ:SBGI). Martin D. Sass has decided this stock is still a good investment and has boosted his fund’s stake by 40% during the same period of time, taking it to 2.78 million shares. The same is valid for Glenn J. Krevlin, who has increased his fund’s stake by 92%. Krevlin’s Glenhill Advisors reportedly holds 2.54 million shares.

Disclosure: none.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!